EVIDENCE & CLINICAL REVIEW · REGISTRY v2026.09.28
Meridian separates the model from the evidence. Changing an LLM later must not change what counts as approved wording. Cards live in the companion as content.js IDs. Status below is honest: named reviewers have not yet signed the set.
Pinned informing sources — not endorsements: NICE NG23 last updated 15 April 2026; The Menopause Society 2022 Hormone Therapy Position Statement; 2023 Nonhormone Therapy Position Statement; 2020 GSM Position Statement; WHO menopause fact sheet. There is no 2024 TMS hormone-therapy position statement in their current directory.
| ID | Source spine | Reviewer | Status |
|---|---|---|---|
| insight.vms / vms-ht | TMS-HT-2022 · NICE-NG23 2026-04-15 | — | Candidate |
| insight.sleep / sleep | NICE; practice summary | — | Candidate |
| insight.mood / mood-window | NICE NG23 mood | — | Candidate |
| insight.fog | Safety summary | — | Candidate |
| care.disrupt | Product + NICE individualized care | — | Candidate |
| care.options | TMS-NONHT-2023 · NICE-NG23 2026-04-15 | — | Candidate |
| care.bleeding | PMB / heavy-bleed safety | — | Candidate |
| care.mood | NICE mood / crisis routing | — | Candidate |
| care.urgent | Emergency vs review split | — | Candidate |
Function remains: track, describe, educate, flag explicit safety conditions, prepare a visit. If you will review cards, email hello@livewithmeridian.com with registration and countries you can speak for.